{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T15:56:57Z","timestamp":1782662217379,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Letrozole, an aromatase inhibitor, has recently been introduced as a favorable medical treatment for ectopic pregnancy. We aimed at evaluating the effects of different doses of letrozole for termination of ectopic pregnancy and study their effects on villous trophoblastic tissue. Sixty patients with undisturbed ectopic pregnancy were classified into three equal groups. Group I: the control group that contained women who underwent laparoscopic salpingectomy, Group II: patients who received letrozole (5\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup>) for 10\u00a0days, and Group III: patients who received letrozole (10\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup>) for 10\u00a0days. Subsequently, the \u03b2-hCG levels were determined on the first day and after 11\u00a0days of treatment. Group IV consisted of patients of GII and GIII; their \u03b2-hCG did not drop below 100 mIU\/ml within 11\u00a0days, and underwent salpingectomy. Placental tissues from patients undergoing salpingectomy either from the control group or GIV were processed for the evaluation of estrogen (ER) and progesterone (PR) receptors, vascular endothelial growth factor (VEGF), and cleaved caspase 3 (CC-3) expression. Cases exposed to high dose letrozole 10\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup> resulted in a higher ectopic pregnancy resolution rate of 85% (17\/20), while the resolution rate of the low dose letrozole-treated group (5\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup>) was 65% (13\/20), and also showed a significant reduction in \u03b2-hCG levels on the 11th day, 25.63\u2009\u00b1\u20094.29 compared to the low dose letrozole group 37.91\u2009\u00b1\u20097.18 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), Meanwhile, the letrozole-treated group GIV showed markedly reduced expression of ER, PR, and VEGF and a significant increase in the apoptotic index cleaved caspase-3 compared to the control group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The utilization of letrozole at a dose of 10\u00a0mg\u00a0day<jats:sup>\u22121<\/jats:sup> for medical treatment of ectopic pregnancy results in a high-successful rate without any severe side effects. Letrozole depriving the placenta of estrogen that had vascular supporting signals resulted in destroying the vascular network with marked apoptosis.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s43032-022-00993-0","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T20:11:23Z","timestamp":1655237483000},"page":"2983-2994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of Different Doses of the Aromatase Inhibitor Letrozole for the Treatment of Ectopic Pregnancy and Its Effect on Villous Trophoblastic Tissue"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-3711","authenticated-orcid":false,"given":"Mohamed Ali","family":"Alabiad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warda M. M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla Hassan","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Taha Abdelfattah","family":"Sharaf ElDin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Ahmed","family":"Khairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Ahmed","family":"Gobran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany Mohamed","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ahmed","family":"Abdelsameea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ismail","family":"Heraiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"issue":"2","key":"993_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/GRF.0b013e3182516d7b","volume":"55","author":"LL Marion","year":"2012","unstructured":"Marion LL, Meeks GR. Ectopic pregnancy: history, incidence, epidemiology, and risk factors. Clin Obstet Gynecol. 2012;55(2):376\u201386.","journal-title":"Clin Obstet Gynecol"},{"key":"993_CR2","doi-asserted-by":"crossref","unstructured":"Medicine PCotASfR. Medical treatment of ectopic pregnancy: a committee opinion. Fertility and sterility. 2013;100(3):638\u201344.","DOI":"10.1016\/j.fertnstert.2013.06.013"},{"issue":"1","key":"993_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/AOG.0000000000000584","volume":"125","author":"Perkins KM, Boulet SL, Kissin DM, Jamieson DJ, Group NAS","year":"2015","unstructured":"Perkins KM, Boulet SL, Kissin DM, Jamieson DJ, Group NAS. Risk of ectopic pregnancy associated with assisted reproductive technology in the United States, 2001\u20132011. Obstet Gynecol. 2015;125(1):70.","journal-title":"Obstet Gynecol"},{"key":"993_CR4","unstructured":"Varma R, Gupta J. Tubal ectopic pregnancy. BMJ Clinical Evidence. 2009;2009."},{"issue":"5","key":"993_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jmig.2015.04.013","volume":"22","author":"N Pereira","year":"2015","unstructured":"Pereira N, Gerber D, Gerber RS, Lekovich JP, Elias RT, Spandorfer SD, et al. Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization-Embryo Transfer Outcomes. J Minim Invasive Gynecol. 2015;22(5):870\u20136.","journal-title":"J Minim Invasive Gynecol"},{"key":"993_CR6","doi-asserted-by":"crossref","unstructured":"Lee VC-Y, Gao J, Lee K-F, Ng EH-Y, Yeung WS-B, Ho P-C. The effect of letrozole with misoprostol for medical termination of pregnancy on the expression of steroid receptors in the placenta. Hum Reprod. 2013;28(11):2912\u20139.","DOI":"10.1093\/humrep\/det345"},{"issue":"11","key":"993_CR7","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/humrep\/dep277","volume":"24","author":"G Tiboni","year":"2009","unstructured":"Tiboni G, Marotta F, Castigliego A, Rossi C. Impact of estrogen replacement on letrozole-induced embryopathic effects. Hum Reprod. 2009;24(11):2688\u201392.","journal-title":"Hum Reprod"},{"issue":"4","key":"993_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S1472-6483(10)60246-5","volume":"17","author":"B Gurates","year":"2008","unstructured":"Gurates B, Parmaksiz C, Kilic G, Celik H, Kumru S, Simsek M. Treatment of symptomatic uterine leiomyoma with letrozole. Reprod Biomed Online. 2008;17(4):569\u201374.","journal-title":"Reprod Biomed Online"},{"key":"993_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bpobgyn.2015.11.016","volume":"34","author":"BN Kashani","year":"2016","unstructured":"Kashani BN, Centini G, Morelli SS, Weiss G, Petraglia F. Role of medical management for uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2016;34:85\u2013103.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"993_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-9-88","volume":"9","author":"S Ferrero","year":"2011","unstructured":"Ferrero S, Venturini PL, Gillott DJ, Remorgida V. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reprod Biol Endocrinol. 2011;9(1):1\u20137.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"993_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.contraception.2017.11.003","volume":"97","author":"CM Nash","year":"2018","unstructured":"Nash CM, Philp L, Shah P, Murphy KE. Letrozole pretreatment prior to medical termination of pregnancy: a systematic review. Contraception. 2018;97(6):504\u20139.","journal-title":"Contraception"},{"issue":"10\u201313","key":"993_CR12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.steroids.2003.09.002","volume":"68","author":"L Shi","year":"2003","unstructured":"Shi L, Shi S-Q, Given RL, Von Hertzen H, Garfield RE. Synergistic effects of antiprogestins and iNOS or aromatase inhibitors on establishment and maintenance of pregnancy. Steroids. 2003;68(10\u201313):1077\u201384.","journal-title":"Steroids"},{"issue":"2\u20133","key":"993_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1387\/ijdb.082758ea","volume":"54","author":"ED Albrecht","year":"2010","unstructured":"Albrecht ED, Pepe GJ. Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy. Int J Dev Biol. 2010;54(2\u20133):397.","journal-title":"Int J Dev Biol"},{"issue":"2","key":"993_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1009465900824","volume":"17","author":"Y Paltieli","year":"2000","unstructured":"Paltieli Y, Eibschitz I, Ziskind G, Ohel G, Silbermann M, Weichselbaum A. High progesterone levels and ciliary dysfunction\u2014a possible cause of ectopic pregnancy. J Assist Reprod Genet. 2000;17(2):103\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"993_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.fertnstert.2003.12.052","volume":"82","author":"PM Lam","year":"2004","unstructured":"Lam PM, Briton-Jones C, Cheung CK, Leung SW, Cheung LP, Haines C. Increased messenger RNA expression of vascular endothelial growth factor and its receptors in the implantation site of the human oviduct with ectopic gestation. Fertil Steril. 2004;82(3):686\u201390.","journal-title":"Fertil Steril"},{"key":"993_CR16","unstructured":"Bancroft JD, Gamble M. Theory and practice of histological techniques: Elsevier health sciences; 2008."},{"issue":"3","key":"993_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1530\/JME-15-0248","volume":"56","author":"SC Kim","year":"2016","unstructured":"Kim SC, Park M-N, Lee YJ, Joo JK, An B-S. Interaction of steroid receptor coactivators and estrogen receptors in the human placenta. J Mol Endocrinol. 2016;56(3):239\u201347.","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"993_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/molehr\/5.5.481","volume":"5","author":"YG Shanker","year":"1999","unstructured":"Shanker YG, Jagannadha RA. Progesterone receptor expression in the human placenta. Mol Hum Reprod. 1999;5(5):481\u20136.","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"993_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1080\/15216549700203701","volume":"42","author":"YG Shanker","year":"1997","unstructured":"Shanker YG, Sharma S, Rao AJ. Expression of progesterone receptor mRNA in the first trimester human placenta. IUBMB Life. 1997;42(6):1235\u201340.","journal-title":"IUBMB Life"},{"key":"993_CR20","doi-asserted-by":"crossref","unstructured":"Alabiad MA, Harb OA, Taha HF, El Shafaay BS, Gertallah LM, Salama N. Prognostic and clinic-pathological significances of SCF and COX-2 expression in inflammatory and malignant prostatic lesions.\u00a0Pathol Oncol Res. 2019;25(2):611\u201324.","DOI":"10.1007\/s12253-018-0534-1"},{"key":"993_CR21","doi-asserted-by":"crossref","unstructured":"Shalaby AM, Aboregela AM, Alabiad MA, El Shaer DF. Tramadol promotes oxidative stress, fibrosis, apoptosis, ultrastructural and biochemical alterations in the adrenal cortex of adult male rat with possible reversibility after withdrawal. Microsc Microanal. 2020;26(3):509\u201323.","DOI":"10.1017\/S1431927620001397"},{"key":"993_CR22","doi-asserted-by":"crossref","unstructured":"Ahmed MM, Gebriel MG, Morad EA, Saber IM, Elwan A, Salah M, Fakhr AE, Shalaby AM, Alabiad MA. Expression of immune checkpoint regulators, cytotoxic T-lymphocyte antigen-4, and programmed death-ligand 1 in epstein-barr virus associated nasopharyngeal carcinoma.\u00a0Appl Immunohistochem Mol Morphol. 2021;29(6):401\u20138.","DOI":"10.1097\/PAI.0000000000000903"},{"key":"993_CR23","doi-asserted-by":"crossref","unstructured":"Tawfeek SE, Shalaby AM, Alabiad MA, Albackoosh A-AAA, Albakoush KMM, Omira MMA. Metanil yellow promotes oxidative stress, astrogliosis, and apoptosis in the cerebellar cortex of adult male rat with possible protective effect of scutellarin: a histological and immunohistochemical study. Tissue Cell. 2021;73:101624.","DOI":"10.1016\/j.tice.2021.101624"},{"issue":"3","key":"993_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00441-004-0969-4","volume":"318","author":"M De Falco","year":"2004","unstructured":"De Falco M, Fedele V, Cobellis L, Mastrogiacomo A, Leone S, Giraldi D, et al. Immunohistochemical distribution of proteins belonging to the receptor-mediated and the mitochondrial apoptotic pathways in human placenta during gestation. Cell Tissue Res. 2004;318(3):599\u2013608.","journal-title":"Cell Tissue Res"},{"issue":"6","key":"993_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.placenta.2003.11.011","volume":"25","author":"R Demir","year":"2004","unstructured":"Demir R, Kayisli U, Seval Y, Celik-Ozenci C, Korgun E, Demir-Weusten A, et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta. 2004;25(6):560\u201372.","journal-title":"Placenta"},{"key":"993_CR26","doi-asserted-by":"crossref","unstructured":"Javanmanesh F, Kashanian M, Mirpang S. Comparison of using misoprostol with or without letrozole in abortion induction: a placebo-controlled clinical trial. Journal of Obstetrics, Gynecology and Cancer Research (JOGCR). 2018;3(2):0-.","DOI":"10.30699\/jogcr.3.2.49"},{"issue":"2","key":"993_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.fertnstert.2020.04.001","volume":"114","author":"MF Mitwally","year":"2020","unstructured":"Mitwally MF, Hozayen WG, Hassanin KM, Abdalla KA, Abdalla NK. Aromatase inhibitor letrozole: a novel treatment for ectopic pregnancy. Fertil Steril. 2020;114(2):361\u20136.","journal-title":"Fertil Steril"},{"issue":"5","key":"993_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1267\/ahc.31.419","volume":"31","author":"A Watanabe","year":"1998","unstructured":"Watanabe A, Yasumizu T, Hoshi K, Katoh R, Kawaoi A, Shibuya M. Vascular endothelial growth factor expression in the rat uterus and placenta throughout pregnancy. Acta Histochem Cytochem. 1998;31(5):419\u201326.","journal-title":"Acta Histochem Cytochem"},{"issue":"12","key":"993_CR29","first-page":"3183","volume":"60","author":"SM Hyder","year":"2000","unstructured":"Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res. 2000;60(12):3183\u201390.","journal-title":"Cancer Res"},{"issue":"20","key":"993_CR30","doi-asserted-by":"publisher","first-page":"10972","DOI":"10.1073\/pnas.200377097","volume":"97","author":"MD Mueller","year":"2000","unstructured":"Mueller MD, Vigne J-L, Minchenko A, Lebovic DI, Leitman DC, Taylor RN. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors \u03b1 and \u03b2. Proc Natl Acad Sci. 2000;97(20):10972\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"1\u20132","key":"993_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0303-7207(99)00003-9","volume":"149","author":"JK Ruohola","year":"1999","unstructured":"Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, H\u00e4rk\u00f6nen PL. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol. 1999;149(1\u20132):29\u201340.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"993_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1210\/endo.133.2.8344219","volume":"133","author":"K Cullinan-Bove","year":"1993","unstructured":"Cullinan-Bove K, Koos RD. Vascular endothelial growth factor\/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 1993;133(2):829\u201337.","journal-title":"Endocrinology"},{"issue":"8","key":"993_CR33","first-page":"3112","volume":"81","author":"JL Shifren","year":"1996","unstructured":"Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab. 1996;81(8):3112\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"993_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1095\/biolreprod64.4.1033","volume":"64","author":"LP Reynolds","year":"2001","unstructured":"Reynolds LP, Redmer DA. Angiogenesis in the placenta. Biol Reprod. 2001;64(4):1033\u201340.","journal-title":"Biol Reprod"},{"issue":"4","key":"993_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/107155769700400401","volume":"4","author":"CY Cheung","year":"1997","unstructured":"Cheung CY. Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecologic Investigation: JSGI. 1997;4(4):169\u201377.","journal-title":"J Soc Gynecologic Investigation: JSGI"},{"key":"993_CR36","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1053\/plac.1999.0524","volume":"21","author":"A Ahmed","year":"2000","unstructured":"Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygen\u2014a review. Placenta. 2000;21:S16\u201324.","journal-title":"Placenta"},{"issue":"1","key":"993_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0897.1997.tb00189.x","volume":"37","author":"DS Torry","year":"1997","unstructured":"Torry DS, Torry RJ. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol. 1997;37(1):21\u20139.","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"993_CR38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0015-0282(99)00417-3","volume":"72","author":"Y Daniel","year":"1999","unstructured":"Daniel Y, Geva E, Lerner-Geva L, Eshed-Englender T, Gamzu R, Lessing JB, et al. Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: is this a novel marker? Fertil Steril. 1999;72(6):1013\u20137.","journal-title":"Fertil Steril"},{"issue":"2","key":"993_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/humrep\/17.2.490","volume":"17","author":"A Felemban","year":"2002","unstructured":"Felemban A, Sammour A, Tulandi T. Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy. Hum Reprod. 2002;17(2):490\u20132.","journal-title":"Hum Reprod"},{"issue":"2","key":"993_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.fertnstert.2003.12.043","volume":"82","author":"SJ Fasouliotis","year":"2004","unstructured":"Fasouliotis SJ, Spandorfer SD, Witkin SS, Liu H-C, Roberts JE, Rosenwaks Z. Maternal serum vascular endothelial growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment. Fertil Steril. 2004;82(2):309\u201313.","journal-title":"Fertil Steril"},{"issue":"12","key":"993_CR41","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1093\/humrep\/17.12.3231","volume":"17","author":"E Kucera-Sliutz","year":"2002","unstructured":"Kucera-Sliutz E, Schiebel I, K\u00f6nig F, Leodolter S, Sliutz G, Koelbl H. Vascular endothelial growth factor (VEGF) and discrimination between abnormal intrauterine and ectopic pregnancy. Hum Reprod. 2002;17(12):3231\u20134.","journal-title":"Hum Reprod"},{"issue":"1","key":"993_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0015-0282(16)57289-6","volume":"63","author":"E Shalev","year":"1995","unstructured":"Shalev E, Peleg D, Tsabari A, Romano S, Bustan M. Spontaneous resolution of ectopic tubal pregnancy: natural history. Fertil Steril. 1995;63(1):15\u20139.","journal-title":"Fertil Steril"},{"issue":"2","key":"993_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/GRF.0b013e3182510aba","volume":"55","author":"LB Craig","year":"2012","unstructured":"Craig LB, Khan S. Expectant management of ectopic pregnancy. Clin Obstet Gynecol. 2012;55(2):461\u201370.","journal-title":"Clin Obstet Gynecol"},{"issue":"10","key":"993_CR44","first-page":"599","volume":"101","author":"E Hendriks","year":"2020","unstructured":"Hendriks E, Rosenberg R, Prine L. Ectopic pregnancy: diagnosis and management. Am Fam Physician. 2020;101(10):599\u2013606.","journal-title":"Am Fam Physician"},{"issue":"4","key":"993_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/09513590.2010.488769","volume":"27","author":"M Aydin","year":"2011","unstructured":"Aydin M, Oktar S, \u00d6zkan OV, Al\u00e7in E, \u00d6zt\u00fcrk OH, Nacar A. Letrozole induces hepatotoxicity without causing oxidative stress: the protective effect of melatonin. Gynecol Endocrinol. 2011;27(4):209\u201315.","journal-title":"Gynecol Endocrinol"},{"key":"993_CR46","doi-asserted-by":"crossref","unstructured":"Gharia B, Seegobin K, Maharaj S, Marji N, Deutch A, Zuberi L. Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature. Oxford medical case reports. 2017;2017(11).","DOI":"10.1093\/omcr\/omx074"},{"key":"993_CR47","doi-asserted-by":"crossref","unstructured":"Pritts EA, Yuen AK, Sharma S, Genisot R, Olive DL. The use of high dose letrozole in ovulation induction and controlled ovarian hyperstimulation. International Scholarly Research Notices. 2011;2011.","DOI":"10.5402\/2011\/242864"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00993-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-00993-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00993-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T15:19:39Z","timestamp":1665069579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-00993-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-00993-0","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"4 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Zagazig University Hospital authorized this study with an approval number of ZU-IRB\/19\/N\/106\/13.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients receive written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}